Ascendis Pharma A/S (ASND)
135.13
-2.32
(-1.69%)
USD |
NASDAQ |
May 31, 16:00
135.13
0.00 (0.00%)
Pre-Market: 20:00
Ascendis Pharma Accounts Payable (Quarterly): 102.08M for March 31, 2024
Accounts Payable (Quarterly) Chart
Historical Accounts Payable (Quarterly) Data
Date | Value |
---|---|
March 31, 2024 | 102.08M |
December 31, 2023 | 104.53M |
September 30, 2023 | 128.66M |
June 30, 2023 | 132.71M |
March 31, 2023 | 143.33M |
December 31, 2022 | 108.35M |
September 30, 2022 | 84.63M |
June 30, 2022 | 78.33M |
March 31, 2022 | 78.89M |
December 31, 2021 | 67.27M |
September 30, 2021 | 88.70M |
June 30, 2021 | 52.61M |
March 31, 2021 | 63.46M |
December 31, 2020 | 26.93M |
September 30, 2020 | 44.74M |
June 30, 2020 | 35.51M |
March 31, 2020 | 30.08M |
December 31, 2019 | 31.10M |
September 30, 2019 | 26.64M |
June 30, 2019 | 24.14M |
Date | Value |
---|---|
March 31, 2019 | 21.60M |
December 31, 2018 | 22.58M |
September 30, 2018 | 36.05M |
June 30, 2018 | 42.33M |
March 31, 2018 | 21.47M |
December 31, 2017 | 20.92M |
September 30, 2017 | 23.08M |
June 30, 2017 | 17.77M |
March 31, 2017 | 18.69M |
December 31, 2016 | 13.83M |
September 30, 2016 | 12.78M |
June 30, 2016 | 11.24M |
March 31, 2016 | 9.449M |
December 31, 2015 | 9.154M |
September 30, 2015 | 6.062M |
June 30, 2015 | 7.822M |
March 31, 2015 | 5.889M |
December 31, 2014 | 6.027M |
September 30, 2014 | 3.862M |
December 31, 2013 | 3.480M |
Accounts Payable Definition
Accounting terminology for money that a company owes to vendors for services or products that it purchased on credit. Accounts payable appear on the balance sheet as a current liability.
Accounts Payable (Quarterly) Range, Past 5 Years
24.14M
Minimum
Jun 2019
143.33M
Maximum
Mar 2023
72.63M
Average
72.80M
Median
Accounts Payable (Quarterly) Benchmarks
Evaxion Biotech AS | -- |
Biodexa Pharmaceuticals Plc | 0.40M |
Trinity Biotech PLC | 20.53M |
NuCana PLC | 7.277M |
TC BioPharm (Holdings) PLC | 2.434M |